<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30644418</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Impaired Nuclear Export of Polyglutamine-Expanded Androgen Receptor in Spinal and Bulbar Muscular Atrophy.</ArticleTitle><Pagination><StartPage>119</StartPage><MedlinePgn>119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-36784-4</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by polyglutamine (polyQ) expansion in the androgen receptor (AR). Prior studies have highlighted the importance of AR nuclear localization in SBMA pathogenesis; therefore, in this study, we sought to determine the role of AR nuclear export in the pathological manifestations of SBMA. We demonstrate here that the nuclear export of polyQ-expanded AR is impaired, even prior to the formation of intranuclear inclusions of aggregated AR. Additionally, we find that promoting AR export with an exogenous nuclear export signal substantially reduces its aggregation and blocks hormone-induced toxicity. Moreover, we show that these protective effects are conferred by destabilization of the mutant protein due to an increase in proteasomal degradation of the cytoplasmic AR. Despite a growing body of evidence that global disruption of nucleo/cytoplasmic transport occurs in ALS and HD, our data suggest that no such global disruption occurs in models of SBMA; rather, AR-specific mechanisms, including reduced phosphorylation at Serine 650, are likely responsible for the impaired nuclear export of polyQ-expanded AR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Frederick J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pluciennik</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merry</LastName><ForeName>Diane E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA. diane.merry@jefferson.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS090335</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C410798">AR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041681" MajorTopicYN="N">NIH 3T3 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016716" MajorTopicYN="N">PC12 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30644418</ArticleId><ArticleId IdType="pmc">PMC6333819</ArticleId><ArticleId IdType="doi">10.1038/s41598-018-36784-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-018-36784-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;79. doi: 10.1038/352077a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671&#x2013;680. doi: 10.1212/WNL.18.7.671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.18.7.671</ArticleId><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, et al. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain. 2006;129:1446&#x2013;1455. doi: 10.1093/brain/awl096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl096</ArticleId><ArticleId IdType="pubmed">16621916</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes LE, et al. Clinical features of spinal and bulbar muscular atrophy. Brain. 2009;132:3242&#x2013;3251. doi: 10.1093/brain/awp258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp258</ArticleId><ArticleId IdType="pmc">PMC2792370</ArticleId><ArticleId IdType="pubmed">19846582</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyu M, et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol. 1992;32:707&#x2013;710. doi: 10.1002/ana.410320517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410320517</ArticleId><ArticleId IdType="pubmed">1449253</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi S, et al. Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology. 1992;42:2300&#x2013;2302. doi: 10.1212/WNL.42.12.2300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.42.12.2300</ArticleId><ArticleId IdType="pubmed">1461383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorar&#xf9; G, et al. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci. 2008;264:100&#x2013;105. doi: 10.1016/j.jns.2007.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.08.012</ArticleId><ArticleId IdType="pubmed">17854832</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding AE, et al. X-linked recessive bulbospinal neuronopathy: a report of ten cases. J Neurol Neurosurg Psychiatry. 1982;45:1012&#x2013;1019. doi: 10.1136/jnnp.45.11.1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.45.11.1012</ArticleId><ArticleId IdType="pmc">PMC491638</ArticleId><ArticleId IdType="pubmed">6890989</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilde J, Moss T, Thrush D. X-linked bulbo-spinal neuronopathy: a family study of three patients. J Neurol Neurosurg Psychiatry. 1987;50:279&#x2013;284. doi: 10.1136/jnnp.50.3.279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.50.3.279</ArticleId><ArticleId IdType="pmc">PMC1031791</ArticleId><ArticleId IdType="pubmed">3031222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue G, et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain. 1989;112(Pt 1):209&#x2013;232. doi: 10.1093/brain/112.1.209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/112.1.209</ArticleId><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Primary sensory neurons in X-linked recessive bulbospinal neuropathy: histopathology and androgen receptor gene expression. Muscle Nerve. 1995;18:301&#x2013;308. doi: 10.1002/mus.880180306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880180306</ArticleId><ArticleId IdType="pubmed">7870107</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann AO. Molecular basis of androgen insensitivity. Mol Cell Endocrinol. 2001;179:105&#x2013;109. doi: 10.1016/S0303-7207(01)00466-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0303-7207(01)00466-X</ArticleId><ArticleId IdType="pubmed">11420135</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35:843&#x2013;854. doi: 10.1016/S0896-6273(02)00834-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00834-6</ArticleId><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen ES, et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci. 2004;24:4778&#x2013;4786. doi: 10.1523/JNEUROSCI.0808-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0808-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopher BL, et al. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron. 2004;41:687&#x2013;699. doi: 10.1016/S0896-6273(04)00082-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(04)00082-0</ArticleId><ArticleId IdType="pubmed">15003169</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, et al. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest. 2006;116:2663&#x2013;2672. doi: 10.1172/JCI28773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI28773</ArticleId><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie HL, et al. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet. 2009;18:1937&#x2013;1950. doi: 10.1093/hmg/ddp115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp115</ArticleId><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB, et al. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron. 2010;67:936&#x2013;952. doi: 10.1016/j.neuron.2010.08.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.08.034</ArticleId><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua JP, et al. Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease. J Clin Invest. 2015;125:831&#x2013;845. doi: 10.1172/JCI73214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI73214</ArticleId><ArticleId IdType="pmc">PMC4319414</ArticleId><ArticleId IdType="pubmed">25607844</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt WB, Welsh MJ. Chaperone functions of the heat shock proteins associated with steroid receptors. Semin Cell Biol. 1994;5:83&#x2013;93. doi: 10.1006/scel.1994.1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/scel.1994.1012</ArticleId><ArticleId IdType="pubmed">7915146</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano LQ, Lavery DN, Bevan CL. Mini-review: Foldosome regulation of androgen receptor action in prostate cancer. Mol Cell Endocrinol. 2013;369:52&#x2013;62. doi: 10.1016/j.mce.2013.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2013.01.023</ArticleId><ArticleId IdType="pubmed">23395916</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheflin L, Keegan B, Zhang W, Spaulding SW. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels. Biochem Biophys Res Commun. 2000;276:144&#x2013;150. doi: 10.1006/bbrc.2000.3424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.3424</ArticleId><ArticleId IdType="pubmed">11006097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi RK, et al. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol. 2000;14:1162&#x2013;1174. doi: 10.1210/mend.14.8.0497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/mend.14.8.0497</ArticleId><ArticleId IdType="pubmed">10935541</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 2002;21:4037&#x2013;4048. doi: 10.1093/emboj/cdf406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdf406</ArticleId><ArticleId IdType="pmc">PMC126152</ArticleId><ArticleId IdType="pubmed">12145204</ArticleId></ArticleIdList></Reference><Reference><Citation>Shank LC, et al. Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro. J Biol Chem. 2008;283:10568&#x2013;10580. doi: 10.1074/jbc.M800810200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800810200</ArticleId><ArticleId IdType="pmc">PMC7486792</ArticleId><ArticleId IdType="pubmed">18270197</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y, et al. Nuclear export signal of androgen receptor (NESAR) regulation of androgen receptor level in human prostate cell lines via ubiquitination and proteasome-dependent degradation. Endocrinology. 2012;153:5716&#x2013;5725. doi: 10.1210/en.2012-1841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2012-1841</ArticleId><ArticleId IdType="pmc">PMC3512072</ArticleId><ArticleId IdType="pubmed">23041672</ArticleId></ArticleIdList></Reference><Reference><Citation>Saporita AJ, et al. Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. J Biol Chem. 2003;278:41998&#x2013;42005. doi: 10.1074/jbc.M302460200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M302460200</ArticleId><ArticleId IdType="pubmed">12923188</ArticleId></ArticleIdList></Reference><Reference><Citation>Poukka H, et al. The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. Journal of cell science. 2000;113(Pt 17):2991&#x2013;3001.</Citation><ArticleIdList><ArticleId IdType="pubmed">10934038</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;tz SV, Cronauer MV, Rinnab L. Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines. J Cell Biochem. 2010;109:1192&#x2013;1200. doi: 10.1002/jcb.22500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.22500</ArticleId><ArticleId IdType="pubmed">20127713</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;tz SV, et al. Inhibition of glycogen synthase kinase-3&#x3b2; counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer. PLoS One. 2011;6:e25341. doi: 10.1371/journal.pone.0025341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025341</ArticleId><ArticleId IdType="pmc">PMC3183056</ArticleId><ArticleId IdType="pubmed">21980429</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh M, et al. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol. 2002;16:2382&#x2013;2392. doi: 10.1210/me.2002-0144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2002-0144</ArticleId><ArticleId IdType="pubmed">12351702</ArticleId></ArticleIdList></Reference><Reference><Citation>Black BE, Holaska JM, Rastinejad F, Paschal BM. DNA binding domains in diverse nuclear receptors function as nuclear export signals. Curr Biol. 2001;11:1749&#x2013;1758. doi: 10.1016/S0960-9822(01)00537-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(01)00537-1</ArticleId><ArticleId IdType="pubmed">11719216</ArticleId></ArticleIdList></Reference><Reference><Citation>Black BE, et al. Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions. Mol Endocrinol. 2004;18:834&#x2013;850. doi: 10.1210/me.2003-0145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2003-0145</ArticleId><ArticleId IdType="pubmed">14684849</ArticleId></ArticleIdList></Reference><Reference><Citation>Gioeli D, et al. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol Endocrinol. 2006;20:503&#x2013;515. doi: 10.1210/me.2005-0351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2005-0351</ArticleId><ArticleId IdType="pubmed">16282370</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Kesler CT, Paschal BM, Balk SP. Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1. J Biol Chem. 2009;284:25576&#x2013;25584. doi: 10.1074/jbc.M109.043133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.043133</ArticleId><ArticleId IdType="pmc">PMC2757959</ArticleId><ArticleId IdType="pubmed">19622840</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitworth H, et al. Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen. PLoS One. 2012;7:e38950. doi: 10.1371/journal.pone.0038950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0038950</ArticleId><ArticleId IdType="pmc">PMC3384611</ArticleId><ArticleId IdType="pubmed">22761715</ArticleId></ArticleIdList></Reference><Reference><Citation>Havel LS, Li S, Li XJ. Nuclear accumulation of polyglutamine disease proteins and neuropathology. Mol Brain. 2009;2:21. doi: 10.1186/1756-6606-2-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-2-21</ArticleId><ArticleId IdType="pmc">PMC2714308</ArticleId><ArticleId IdType="pubmed">19575804</ArticleId></ArticleIdList></Reference><Reference><Citation>Klement IA, et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 1998;95:41&#x2013;53. doi: 10.1016/S0092-8674(00)81781-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81781-X</ArticleId><ArticleId IdType="pubmed">9778246</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J, et al. Ataxin-7 can export from the nucleus via a conserved exportin-dependent signal. J Biol Chem. 2006;281:2730&#x2013;2739. doi: 10.1074/jbc.M506751200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M506751200</ArticleId><ArticleId IdType="pubmed">16314424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bichelmeier U, et al. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J Neurosci. 2007;27:7418&#x2013;7428. doi: 10.1523/JNEUROSCI.4540-06.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4540-06.2007</ArticleId><ArticleId IdType="pmc">PMC6672614</ArticleId><ArticleId IdType="pubmed">17626202</ArticleId></ArticleIdList></Reference><Reference><Citation>Breuer P, Haacke A, Evert BO, W&#xfc;llner U. Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control. J Biol Chem. 2010;285:6532&#x2013;6537. doi: 10.1074/jbc.M109.036335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.036335</ArticleId><ArticleId IdType="pmc">PMC2825449</ArticleId><ArticleId IdType="pubmed">20064935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Li A, Holmes BB, Marasa JC, Diamond MI. An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1. J Biol Chem. 2013;288:6063&#x2013;6071. doi: 10.1074/jbc.M112.413575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.413575</ArticleId><ArticleId IdType="pmc">PMC3585045</ArticleId><ArticleId IdType="pubmed">23319588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornett J, et al. Polyglutamine expansion of huntingtin impairs its nuclear export. Nat Genet. 2005;37:198&#x2013;204. doi: 10.1038/ng1503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1503</ArticleId><ArticleId IdType="pubmed">15654337</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai Y, Shao J, Miller VM, Williams A, Paulson HL. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci USA. 2002;99:9310&#x2013;9315. doi: 10.1073/pnas.152101299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.152101299</ArticleId><ArticleId IdType="pmc">PMC123137</ArticleId><ArticleId IdType="pubmed">12084819</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin S, et al. RNA association and nucleocytoplasmic shuttling by ataxin-1. J Cell Sci. 2005;118:233&#x2013;242. doi: 10.1242/jcs.01611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01611</ArticleId><ArticleId IdType="pubmed">15615787</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeyama K, et al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron. 2002;35:855&#x2013;864. doi: 10.1016/S0896-6273(02)00875-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00875-9</ArticleId><ArticleId IdType="pubmed">12372281</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am J Pathol. 1998;153:695&#x2013;701. doi: 10.1016/S0002-9440(10)65612-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)65612-X</ArticleId><ArticleId IdType="pmc">PMC1853004</ArticleId><ArticleId IdType="pubmed">9736019</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol. 1998;44:249&#x2013;254. doi: 10.1002/ana.410440216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440216</ArticleId><ArticleId IdType="pubmed">9708548</ArticleId></ArticleIdList></Reference><Reference><Citation>Walcott JL, Merry DE. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J Biol Chem. 2002;277:50855&#x2013;50859. doi: 10.1074/jbc.M209466200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209466200</ArticleId><ArticleId IdType="pubmed">12388541</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr CR, et al. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. J Biol Chem. 2010;285:35567&#x2013;35577. doi: 10.1074/jbc.M110.146845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.146845</ArticleId><ArticleId IdType="pmc">PMC2975181</ArticleId><ArticleId IdType="pubmed">20826791</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie HL, Pestell RG, Merry DE. SIRT1 modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA. J Neurosci. 2011;31:17425&#x2013;17436. doi: 10.1523/JNEUROSCI.3958-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3958-11.2011</ArticleId><ArticleId IdType="pmc">PMC6088793</ArticleId><ArticleId IdType="pubmed">22131404</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H, et al. A polyglutamine expansion disease protein sequesters PTIP to attenuate DNA repair and increase genomic instability. Hum Mol Genet. 2012;21:4225&#x2013;4236. doi: 10.1093/hmg/dds246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds246</ArticleId><ArticleId IdType="pmc">PMC3441122</ArticleId><ArticleId IdType="pubmed">22736030</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua JP, et al. Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy. Hum Mol Genet. 2014;23:1376&#x2013;1386. doi: 10.1093/hmg/ddt527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt527</ArticleId><ArticleId IdType="pmc">PMC3919011</ArticleId><ArticleId IdType="pubmed">24150846</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger TR, Montie HL, Jain P, Legleiter J, Merry DE. Identification of novel polyglutamine-expanded aggregation species in spinal and bulbar muscular atrophy. Brain Res. 2015;1628:254&#x2013;264. doi: 10.1016/j.brainres.2015.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.09.033</ArticleId><ArticleId IdType="pmc">PMC4681586</ArticleId><ArticleId IdType="pubmed">26453288</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine EM, et al. Proteasome-mediated proteolysis of the polyglutamine-expanded androgen receptor is a late event in spinal and bulbar muscular atrophy (SBMA) pathogenesis. J Biol Chem. 2015;290:12572&#x2013;12584. doi: 10.1074/jbc.M114.617894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.617894</ArticleId><ArticleId IdType="pmc">PMC4432278</ArticleId><ArticleId IdType="pubmed">25795778</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, Meinkoth JL, Tsien RY, Taylor SS. Identification of a signal for rapid export of proteins from the nucleus. Cell. 1995;82:463&#x2013;473. doi: 10.1016/0092-8674(95)90435-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90435-2</ArticleId><ArticleId IdType="pubmed">7634336</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss A, et al. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington&#x2019;s disease. J Neurochem. 2008;104:846&#x2013;858. doi: 10.1111/j.1471-4159.2007.05032.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.05032.x</ArticleId><ArticleId IdType="pubmed">17986219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sontag EM, et al. Detection of Mutant Huntingtin Aggregation Conformers and Modulation of SDS-Soluble Fibrillar Oligomers by SmallMolecules. J Huntingtons Dis. 2012;1:119&#x2013;132. doi: 10.3233/JHD-2012-129004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JHD-2012-129004</ArticleId><ArticleId IdType="pmc">PMC3786168</ArticleId><ArticleId IdType="pubmed">24086178</ArticleId></ArticleIdList></Reference><Reference><Citation>Sontag EM, et al. Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington&#x2019;s disease models. J Neurosci. 2012;32:11109&#x2013;11119. doi: 10.1523/JNEUROSCI.0895-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0895-12.2012</ArticleId><ArticleId IdType="pmc">PMC3546821</ArticleId><ArticleId IdType="pubmed">22875942</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J, et al. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol. 2011;7:925&#x2013;934. doi: 10.1038/nchembio.694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.694</ArticleId><ArticleId IdType="pmc">PMC3271120</ArticleId><ArticleId IdType="pubmed">22037470</ArticleId></ArticleIdList></Reference><Reference><Citation>Junn E, Leee SS, Suhr UT, Mouradian MM. Parkin accumulation in aggresomes due to proteasome impairment. J Biol Chem. 2002;277:47870&#x2013;47877. doi: 10.1074/jbc.M203159200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203159200</ArticleId><ArticleId IdType="pubmed">12364339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaguchi Y, et al. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell. 2003;115:727&#x2013;738. doi: 10.1016/S0092-8674(03)00939-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(03)00939-5</ArticleId><ArticleId IdType="pubmed">14675537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Qian SB. Chaperone-mediated hierarchical control in targeting misfolded proteins to aggresomes. Mol Biol Cell. 2011;22:3277&#x2013;3288. doi: 10.1091/mbc.e11-05-0388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e11-05-0388</ArticleId><ArticleId IdType="pmc">PMC3172255</ArticleId><ArticleId IdType="pubmed">21775628</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 1998;143:1883&#x2013;1898. doi: 10.1083/jcb.143.7.1883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.143.7.1883</ArticleId><ArticleId IdType="pmc">PMC2175217</ArticleId><ArticleId IdType="pubmed">9864362</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinnab L, et al. Inhibition of glycogen synthase kinase-3 in androgen-responsive prostate cancer cell lines: are GSK inhibitors therapeutically useful? Neoplasia. 2008;10:624&#x2013;634. doi: 10.1593/neo.08248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1593/neo.08248</ArticleId><ArticleId IdType="pmc">PMC2386547</ArticleId><ArticleId IdType="pubmed">18516299</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology. 2004;145:2941&#x2013;2949. doi: 10.1210/en.2003-1519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2003-1519</ArticleId><ArticleId IdType="pubmed">14988390</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazor M, Kawano Y, Zhu H, Waxman J, Kypta RM. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth. Oncogene. 2004;23:7882&#x2013;7892. doi: 10.1038/sj.onc.1208068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1208068</ArticleId><ArticleId IdType="pubmed">15361837</ArticleId></ArticleIdList></Reference><Reference><Citation>Salas TR, et al. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity. J Biol Chem. 2004;279:19191&#x2013;19200. doi: 10.1074/jbc.M309560200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M309560200</ArticleId><ArticleId IdType="pubmed">14985354</ArticleId></ArticleIdList></Reference><Reference><Citation>Medunjanin S, et al. Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity. J Biol Chem. 2005;280:33006&#x2013;33014. doi: 10.1074/jbc.M506758200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M506758200</ArticleId><ArticleId IdType="pubmed">16076840</ArticleId></ArticleIdList></Reference><Reference><Citation>Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol Cell Biol. 2008;28:7309&#x2013;7322. doi: 10.1128/MCB.00808-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00808-08</ArticleId><ArticleId IdType="pmc">PMC2593428</ArticleId><ArticleId IdType="pubmed">18838540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio-Pati&#xf1;o C, et al. Glycogen synthase kinase-3&#x3b2; is involved in ligand-dependent activation of transcription and cellular localization of the glucocorticoid receptor. Mol Endocrinol. 2012;26:1508&#x2013;1520. doi: 10.1210/me.2011-1366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2011-1366</ArticleId><ArticleId IdType="pmc">PMC5416974</ArticleId><ArticleId IdType="pubmed">22771494</ArticleId></ArticleIdList></Reference><Reference><Citation>Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem. 1997;272:24735&#x2013;24738. doi: 10.1074/jbc.272.40.24735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.40.24735</ArticleId><ArticleId IdType="pubmed">9312064</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat Neurosci. 2016;19:668&#x2013;677. doi: 10.1038/nn.4272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4272</ArticleId><ArticleId IdType="pmc">PMC5138863</ArticleId><ArticleId IdType="pubmed">26998601</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Grima JC, et al. Mutant Huntingtin Disrupts the Nuclear Pore Complex. Neuron. 2017;94:93&#x2013;107.e106. doi: 10.1016/j.neuron.2017.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.03.023</ArticleId><ArticleId IdType="pmc">PMC5595097</ArticleId><ArticleId IdType="pubmed">28384479</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, et al. Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport. Neuron. 2017;94:48&#x2013;57.e44. doi: 10.1016/j.neuron.2017.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.03.027</ArticleId><ArticleId IdType="pmc">PMC5479704</ArticleId><ArticleId IdType="pubmed">28384474</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Nollen EA, Kitagawa K, Bindokas VP, Morimoto RI. Polyglutamine protein aggregates are dynamic. Nat Cell Biol. 2002;4:826&#x2013;831. doi: 10.1038/ncb863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb863</ArticleId><ArticleId IdType="pubmed">12360295</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H, et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol. 2009;65:140&#x2013;150. doi: 10.1002/ana.21540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21540</ArticleId><ArticleId IdType="pubmed">19259967</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, et al. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9:875&#x2013;884. doi: 10.1016/S1474-4422(10)70182-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70182-4</ArticleId><ArticleId IdType="pubmed">20691641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Rhodes LE, et al. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol. 2011;10:140&#x2013;147. doi: 10.1016/S1474-4422(10)70321-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70321-5</ArticleId><ArticleId IdType="pmc">PMC3056353</ArticleId><ArticleId IdType="pubmed">21216197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashizume A, et al. Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study. J Neurol Neurosurg Psychiatry. 2017;88:1026&#x2013;1032. doi: 10.1136/jnnp-2017-316015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316015</ArticleId><ArticleId IdType="pubmed">28780536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J, et al. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature. 2008;452:713&#x2013;718. doi: 10.1038/nature06731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06731</ArticleId><ArticleId IdType="pmc">PMC2377396</ArticleId><ArticleId IdType="pubmed">18337722</ArticleId></ArticleIdList></Reference><Reference><Citation>Koryakina Y, Ta HQ, Gioeli D. Androgen receptor phosphorylation: biological context and functional consequences. Endocr Relat Cancer. 2014;21:T131&#x2013;145. doi: 10.1530/ERC-13-0472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/ERC-13-0472</ArticleId><ArticleId IdType="pmc">PMC4437516</ArticleId><ArticleId IdType="pubmed">24424504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou ZX, Kemppainen JA, Wilson EM. Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol Endocrinol. 1995;9:605&#x2013;615. doi: 10.1210/mend.9.5.7565807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/mend.9.5.7565807</ArticleId><ArticleId IdType="pubmed">7565807</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponguta LA, Gregory CW, French FS, Wilson EM. Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer. J Biol Chem. 2008;283:20989&#x2013;21001. doi: 10.1074/jbc.M802392200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M802392200</ArticleId><ArticleId IdType="pmc">PMC2475695</ArticleId><ArticleId IdType="pubmed">18511414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccarello D, et al. Detailed functional studies on androgen receptor mild mutations demonstrate their association with male infertility. Clin Endocrinol (Oxf) 2008;68:580&#x2013;588. doi: 10.1111/j.1365-2265.2007.03069.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2007.03069.x</ArticleId><ArticleId IdType="pubmed">17970778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferlin A, et al. Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations. Clin Endocrinol (Oxf) 2006;65:606&#x2013;610. doi: 10.1111/j.1365-2265.2006.02635.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2006.02635.x</ArticleId><ArticleId IdType="pubmed">17054461</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Q, et al. Expression of androgen receptor and its phosphorylated forms in breast cancer progression. Cancer. 2013;119:2532&#x2013;2540. doi: 10.1002/cncr.28092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.28092</ArticleId><ArticleId IdType="pmc">PMC3874891</ArticleId><ArticleId IdType="pubmed">23605249</ArticleId></ArticleIdList></Reference><Reference><Citation>Woerner AC, et al. Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science. 2016;351:173&#x2013;176. doi: 10.1126/science.aad2033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad2033</ArticleId><ArticleId IdType="pubmed">26634439</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi H, et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain. 2005;128:659&#x2013;670. doi: 10.1093/brain/awh381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh381</ArticleId><ArticleId IdType="pubmed">15659427</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K, et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain. 2008;131:229&#x2013;239. doi: 10.1093/brain/awm289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm289</ArticleId><ArticleId IdType="pubmed">18056738</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J Neurosci. 1998;18:9673&#x2013;9684. doi: 10.1523/JNEUROSCI.18-23-09673.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-23-09673.1998</ArticleId><ArticleId IdType="pmc">PMC6793286</ArticleId><ArticleId IdType="pubmed">9822728</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S, Snow CJ, Paschal BM. A pathway linking oxidative stress and the Ran GTPase system in progeria. Mol Biol Cell. 2014;25:1202&#x2013;1215. doi: 10.1091/mbc.E13-07-0430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E13-07-0430</ArticleId><ArticleId IdType="pmc">PMC3982987</ArticleId><ArticleId IdType="pubmed">24523287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>